Terapia génica
La terapia génica administra una copia funcional de un gen, o corrige uno defectuoso, generalmente una sola vez y para toda la vida. Fabricar el vector que la administra suele ser más difícil que diseñar la terapia.
132 acciones
| # | Nombre | Posición | Valor operado |
Acciones del tema |
% del portafolio | Estado | |
|---|---|---|---|---|---|---|---|
| 26 |
UBS Group
Zurich,
Switzerland
| USD 906 M | -USD 225 M | 83 | 0.11% | Reducidas |
|
| 27 |
Farallon Capital Management
San Francisco,
California
| USD 877 M | +USD 158 M | 4 | 4.05% | Aumentadas |
|
| 28 |
ARK Investment Management
St. Petersburg,
Florida
| USD 834 M | -USD 56.2 M | 4 | 5.39% | Reducidas |
|
| 29 |
RA Capital Management
Boston,
Massachusetts
| USD 830 M | +USD 131 M | 12 | 7.22% | Aumentadas |
|
| 30 |
Viking Global Investors
Stamford,
Connecticut
| USD 766 M | -USD 109 M | 2 | 2.18% | Reducidas |
|
| 31 |
D.E. Shaw & Co
New York
| USD 737 M | +USD 114 M | 32 | 0.35% | Aumentadas |
|
| 32 |
Charles Schwab
San Francisco,
California
| USD 706 M | -USD 15 M | 45 | 0.09% | Reducidas |
|
| 33 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| USD 666 M | -USD 240 M | 10 | 0.44% | Reducidas |
|
| 34 |
Millennium Management
New York
| USD 643 M | -USD 74.1 M | 49 | 0.23% | Reducidas |
|
| 35 |
Suvretta Capital Management
New York
| USD 629 M | +USD 10.5 M | 9 | 11.51% | Aumentadas |
|
| 36 |
Ameriprise
Minneapolis,
Minnesota
| USD 558 M | -USD 25 M | 27 | 0.11% | Reducidas |
|
| 37 |
Capital World Investors
Los Angeles,
California
| USD 551 M | -USD 11.7 M | 3 | 0.07% | Reducidas |
|
| 38 |
Adage Capital Partners
Boston,
Massachusetts
| USD 540 M | +USD 161 M | 16 | 0.76% | Aumentadas |
|
| 39 |
Gilead Sciences
Foster City,
California
| USD 537 M | -USD 772 M | 2 | 32.57% | Reducidas |
|
| 40 |
Allspring Global Investments
Charlotte,
North Carolina
| USD 537 M | -USD 32.1 M | 11 | 0.82% | Reducidas |
|
| 41 |
Harris Associates
Chicago,
Illinois
| USD 508 M | +USD 15.6 M | 1 | 0.67% | Aumentadas |
|
| 42 |
Raymond James Financial
St Petersburg,
Florida
| USD 494 M | -USD 9.7 M | 36 | 0.13% | Reducidas |
|
| 43 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
| USD 490 M | -USD 10.9 M | 72 | 0.11% | Reducidas |
|
| 44 |
Hood River Capital Management
Palm Beach Gardens,
Florida
| USD 489 M | +USD 24.2 M | 3 | 3.54% | Aumentadas |
|
| 45 |
AQR Capital Management
Greenwich,
Connecticut
| USD 480 M | +USD 26.4 M | 34 | 0.17% | Aumentadas |
|
| 46 |
Principal Financial Group
Des Moines,
Iowa
| USD 470 M | -USD 10.2 M | 14 | 0.23% | Reducidas |
|
| 47 |
Soleus Capital Management
Greenwich,
Connecticut
| USD 469 M | -USD 46.4 M | 5 | 16.15% | Reducidas |
|
| 48 |
Renaissance Technologies
New York
| USD 452 M | +USD 19.2 M | 52 | 0.62% | Aumentadas |
|
| 49 |
William Blair Investment Management
Chicago,
Illinois
| USD 441 M | +USD 179 M | 3 | 1.33% | Aumentadas |
|
| 50 |
Envestnet Asset Management
Chicago,
Illinois
| USD 430 M | +USD 4.5 M | 17 | 0.1% | Aumentadas |
|